C5 and paroxysmal nocturnal hemoglobinuria: Coversin (Nomacopan) has been studied for conditions such as bullous pemphigoid and PNH as an anti-complement therapy targeting both C5 and leukotriene B4, aiming to reduce inflammation and prevent vascular damage [60].